UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report: ~~April~~May 2126, ~~2015~~2017

(Date of earliest event reported)

BIOLOG, INC.

(Exact name of registrant as specified in its charter)

Utah --------------------------------	000-53696 --------------------------------	87-0279370 ----------------------------------------------
(State of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

41223 ~~Colonial~~W Belden Avenue

~~Albany~~Syeacuse, New York ~~12203~~12304

--------------------------------------------------------------

(Address of principal executive offices) (Zip Code)

(~~701~~315) ~~388~~701-~~9990~~10320

---------------------------------------------------------------

(Registrant’'s telephone no., including area code)

~~123~~4 ~~Parker~~Colonial Avenue, ~~Liverpool~~Albany, NY ~~13088~~ 12203

---------------------------------------------------------------

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1ITEM 4.01 CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT

~~SECTION~~On 5May –26, ~~CORPORATE~~2017, ~~GOVERNANCE~~Board ~~AND~~of ~~MANAGEMENT~~Directors of the Company approved the termination of MaloneBailey, LLP (“MaloneBailey”) as the Company’s independent registered public accounting firm.

~~Item~~Concurrent ~~5.01 Changes~~with inthis ~~Control~~action, Board of ~~Registrant~~Directors of the Company ratified and approved the appointment of Boyle CPA, LLC (“Boyle”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016 and its engagement agreement dated May 25, 2017. Boyle is located at P.O. Box 726. Red Bank, New Jersey 07701.

OnThe ~~April~~Company’s financial ~~21,~~statements ~~2015 a change in control~~ of the ~~Registrant~~fiscal ~~took~~years ~~place~~ended ~~when~~December ~~Joseph~~31, C.2014 were ~~Passalaqua~~audited ~~sold~~by ~~his~~MaloneBaileye’s ~~Twenty~~report ~~Five~~on ~~Million~~our financial ~~Six Thousand Nine Hundred Thirty (25~~statements,~~006,930)~~ ~~common~~which ~~stock~~did ~~that~~not ~~were~~contain ~~never~~an ~~registered~~adverse inopinion, ~~any~~a ~~Registration~~disclaimer ~~Statement~~of ~~under~~opinion, ~~the~~nor ~~Securities~~was ~~Act~~it ofqualified ~~1933~~or ~~with~~modified ~~the~~as ~~U.S.~~to ~~Securities~~uncertainty, ~~and~~audit ~~Exchange~~scope ~~Commission~~or asaccounting ~~amended~~principles. ~~out~~MaloneBailey's report ofon aour ~~total~~financial ofstatements ~~Forty~~for ~~Million~~the ~~Four~~fiscal ~~Hundred~~year ~~Thirty~~ended ~~Six~~December ~~Thousand~~31, ~~Seven~~2013 ~~Hundred~~through ~~Forty~~March ~~(40~~30,~~436~~ 2014,~~740)~~ ~~shares~~however, ofstated ~~common~~that ~~stock~~there ~~issued~~is ~~and~~substantial ~~outstanding~~doubt asabout of the ~~date~~Company’s ~~hereof~~ability to ~~Gerald~~continue ~~Fay~~as ~~(the~~a ~~"Control~~going ~~Shares") an indivdual unrelated to Mr~~concern. ~~Passalaqua.~~

~~Item~~During ~~5.02 Departures~~the fiscal years ended December 31, 2015 and through May 25, 2017, (a) there were no disagreements with Enterprise on any matter of ~~Directors~~accounting principles or ~~Certain~~practices, ~~Officers;~~financial ~~Election~~statement ofdisclosure, ~~Directors;~~auditing ~~Appointment~~scope or procedure, which disagreements, if not resolved to the satisfaction of ~~Certain~~Stegman, ~~Officers;~~would ~~Compensatory~~have ~~Arrangements~~caused it to make reference to the subject matter of ~~Certain~~the ~~Officers~~disagreement in connection with its report on the financial statements for such years and (b) there were no “reportable events” as described in Item 304(a)(1)(v) of Regulation S-K.

OnThe ~~April~~Company ~~21,~~has ~~2015~~provided MaloneBailey with a copy of this Form 8-K prior to its filing with the ~~Common~~Securities ~~Stock~~and ~~Purchase~~Exchange ~~Agreement~~Commission ~~from~~(“SEC”) ~~Joseph~~and C.requested ~~Pasalaqua~~MaloneBailey to ~~Gerald~~furnish ~~Fay was approved~~a ~~unanimously~~letter byaddressed to the ~~Board~~SEC ofstating ~~Directors and~~whether byit agrees with the ~~shareholders~~statements atmade aabove. To ~~Special~~be ~~Meeting~~filed herewith as Exhibit 16.1 is a copy of MaloneBailey's letter to the ~~Shareholders~~SEC dated May 25, 2017.

InDuring ~~accordance with~~ the ~~Special~~Company's ~~Meeting~~previous fiscal ofyears ~~the~~ended ~~Shareholders~~December 31, ~~Joseph~~2016 through C.May ~~Passalaqua~~25, ~~Gary~~2017, ~~McHenry~~neither ~~and~~the ~~Devon~~Company ~~Nish resigned~~nor asanyone ~~Director~~on ~~and~~the ~~Officer~~Company's ofbehalf ~~the~~consulted ~~Registrant~~with ~~and~~MaloneBailey ~~Gerald~~regarding ~~Fay~~either ~~was~~(i) ~~elected~~the asapplication aof ~~Director,~~accounting ~~and~~principles ~~appointed~~to asa ~~Chief~~specified ~~Executive~~transaction, ~~Officer~~either ofcompleted ~~the~~or ~~Registrant~~proposed, ~~Gerald~~or M.the ~~Healley~~type ~~was~~of ~~elected~~audit asopinion athat ~~Director~~might ~~and~~be ~~appointed~~rendered ason ~~Vice~~the ~~President~~Company's ~~and~~financial ~~Chief~~statements ~~Financial~~or ~~Officer,~~(ii) ~~and~~any ~~Pat~~matter ~~Scorzelli~~that was ~~elected~~either asthe asubject ~~Director,~~of ~~and~~a ~~appointed~~disagreement asor ~~Vice~~a ~~President~~reportable ~~and~~event ~~Chief~~as ~~Operating~~defined ~~Officer~~in Item 304(a)(1)(v) of ~~the Registrant~~Regulation S-K.

~~Gerald~~The ~~Fay,~~Company has ~~been~~authorized ~~in businessman~~MaloneBailey ~~for over 40 years running companies including logistics in the oil industry, energy sector, and medical technology. As a Native American, he has worked with Native Americans~~ to ~~develop Dakota~~ ~~Native~~respond ~~Energy~~fully ~~Corporation which is dedicated~~ to ~~infrastructure and~~all ~~energy~~inquiries ~~projects and a nationwide jobs program. His has worked as a consultant for political leaders such as Vice President~~ of ~~the United States Nelson A~~Boyle. Rockefeller, medical leaders such as Elimer Gabrieli, the world's leader in medical informatics. He has served as a consultant for various businesses and has successfully funded many ventures. Mr. Fay was invilved in the invention of a scholastic emergency medical identification packet collaborated with Dr. Gabrielli, an employee emergency medical identification program for General Electric proposed by the IUE. He designed a comprehensive buyers program for the AF of L - CIO, the invention of the discount cards formerly called the Power Card Program. Mr. Fay was CEO of both Bio-Science Organic Solutions LLC and GFT Company LLC and has a research agreement with Johns Hopkins University Bloomberg School of Public Health. Dr. Nirbhay Kumar, a professor at the Johns Hopkins, worked in an advisory capacity and was on staff with him in his North Dakota Company, Bio-Science Organic Solutions LLC. Mr. Fay has extensive

~~Pat~~ITEM Scorzelli, in his capacity as President of Matrix Consulting Group, has served as a key advisor to multiple private and public companies on business, finance and legal matters over the past three decades5.02 DEPARTURES HeOF ~~has~~DIRECTORS OR ~~assisted~~CERTAIN ~~both~~OFFICERS; ELECTION ~~existing~~OF ~~and~~DIRECTORS; APPOINTMENT ~~start-up~~OF ~~businesses~~CERTAIN inOFFICERS; ~~their~~COMPENSATORY ~~efforts~~ARRANGEMENTS toOF ~~realize~~CERTAIN ~~their true corporate potential in a highly competitive environment~~OFFICERS. During this time he has held the titles of Chairman, CEO and President for such companies as US Global Nanospace, Inc., a publicly traded defense, nanotech and biotech company, 3G NanoSystems, Inc., a renewable energy development company, Scanbuy, Inc., a mobile barcode solutions company, International Wireless Communications, Inc., a wireless technology software developer, Qik Technology and TriGenex Corporation, both startup companies operating in the biotech industry and Barefoot Limited Partners, a $30M development and construction company. Mr. Scorzelli also serves as an advisor to SEC Attorneys, a private securities law firm that deals with business and securities issues. He also holds the position of Managing Partner for First Union Venture Group, a venture capital and merger and acquisition firm and also held a Managing Partner position with Harvard Capital Partners, a private equity, real estate development and investment firm.

~~Mike~~ On ~~Healey~~May ~~has~~26, ~~been~~2017 In ~~involved~~accordance inwith the ~~construction~~Special ~~industry~~Meeting ~~for~~of ~~over~~the 30Shareholders, ~~years. The~~Gerald ~~past~~Fay, 15Pat ~~years~~Scorzelli heand ~~has~~Mike ~~been~~Healey resigned ~~working~~ as aDirector ~~real~~and ~~estate~~Officer ~~developer. For~~of the ~~past~~Registrant 17and ~~years~~Shelli heFields of ~~has~~Syracuse, ~~worked~~New York was elected as a ~~commercial~~Director, ~~real~~and ~~estate~~appointed ~~broker.~~ as Chief Executive Officer of the Registrant

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d)

Exhibits

Exhibit No.	Description of Exhibit

16.1	Letter from Auditors to the Securities aNd Exchange Comission dated May 26, 2017

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized .

		BIOLOG, INC.
		(Registrant)
	Date: April 21, 2015	By: /s/ GERALD FAY
	Date: May 26, 2017	By: /s/ SHELLI FIELDS
		Gerald Fay
		Shelli Fields
		Chief Executive Officer and
		Director
		(Duly Authorized Officer)

Filing Compare · Biolog, Inc